I agree with your counter-indication view. It also allows those who have done their research to buy more lower, as the price gets trickled down.
I'm mostly concerned with new arrivals being put off by carpet bombing negatives, lies about IPIX and Leo Ehrlich, and crazy reversals that confuse, and thus dissuade.
IPIX has good results from 3 different phase 2 trials, plus validating science from related academic and medical articles, yet the confident voices of longs who have been around a while cannot outdo or undo algorithms combined with concerted psychological warfare.
At least until positive news comes and arrives like a tsunami. Remains to be seen but at this moment silence feels golden.